COVID-19 Notice: We are providing FREE consultations via phone or video conferencing for your safety and convenience. Learn More »
Published on:

News Roundup

  • Santarus files for approval to FDA for anti-swelling drug Rhucin.
  • Prescription Drug Coverage Is an Important Part of Your Health Care: Medicare Part D Needs to be Considered.
  • Bone-Damage Concerns Lead to Halt of Pain-Drug Tests -Bloomberg
  • FDA Needs Four More Weeks to Review MannKind’s Diabetes Drug Afrezza.